alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Hill, Utah

Email this event to me @

Invalid Email Address!Invalid Email Address!

**Start Date/Time:**

Monday, September 1, 2025 12:30 PM

**End Date/Time:**

Tuesday, September 30, 2025 1:00 PM

**Description:**

During the month of September, Defense Logistics Agency Distribution Hill, Utah, will transition to the Warehouse Management System. Customers with questions or concerns about their material are encouraged to reach out via the contact information foundon the Hill, Utah, location page.

Enrolled Users:

                - Return
                - 
                - Export
No. 10-7547.

#### James D. Allen, Petitioner v. L. E. Scribner, Warden, et al.

562 U.S. 1186, 131 S. Ct. 1012,

178 L. Ed. 2d 840,

2011 U.S. LEXIS 723.

January 18, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 392 Fed. Appx. 565.
# C_2016305EN.01000602.xml

| 22.8.2016 | EN | Official Journal of the European Union | C 305/6 |
| --- | --- | --- | --- |

22.8.2016

EN

Official Journal of the European Union

C 305/6

---

Judgment of the Court (Grand Chamber) of 14 June 2016 — Jean-Charles Marchiani v European Parliament

(Case C-566/14 P) (1)

1

((Appeal - Member of the European Parliament - Parliamentary assistance allowance - Recovery of undue payments - Recovery - Implementing Measures of the Statute for Members of the Parliament - Respect for the rights of the defence - Principle of impartiality - Limitation - Regulation (EU, Euratom) No 966/2012 - Articles 78 to 81 - Delegated Regulation (EU) No 1268/2012 - Articles 81, 82 and 93 - Principle of protection of legitimate expectations - Reasonable time))

(2016/C 305/09)

Language of the case: French

Parties

Parties

Appellant: Jean-Charles Marchiani (represented by: C.S. Marchiani, avocat)

Appellant:

Other party to the proceedings: European Parliament (represented by: G. Corstens and S. Seyr, acting as Agents)

Other party to the proceedings:

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the appeal; |
| --- | --- |

1.

Dismisses the appeal;

| 2. | Orders Mr Jean-Charles Marchiani to pay the costs. |
| --- | --- |

2.

Orders Mr Jean-Charles Marchiani to pay the costs.

---

(1)  OJ C 34, 2.2.2015.

1

---
# C_2016106EN.01000701.xml

| 21.3.2016 | EN | Official Journal of the European Union | C 106/7 |
| --- | --- | --- | --- |

21.3.2016

EN

Official Journal of the European Union

C 106/7

---

Judgment of the Court (Fifth Chamber) of 28 January 2016 — Quimitéchnica.com — Comércio e Indústria Química, SA, José de Mello — Sociedade Gestora de Participações Sociais, SA v European Commission

(Case C-415/14 P) (1)

1

((Appeal - Cartels - European market in phosphates for animal feed - Fine imposed on the appellants following a settlement procedure - Payment of the fine in instalments - Requirement to provide a bank guarantee at a bank with a long-term ‘AA’ credit rating - Duty to state reasons))

(2016/C 106/08)

Language of the case: Portuguese

Parties

Parties

Appellants: Quimitéchnica.com — Comércio e Indústria Química, SA, José de Mello — Sociedade Gestora de Participações Sociais, SA (represented by: J. Calheiros, lawyer)

Appellants:

Other party to the proceedings: European Commission (represented by: V. Bottka and B. Mongin, acting as Agents, and M. Marques Mendes, lawyer)

Other party to the proceedings:

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Sets aside the judgment of the General Court of the European Union of 26 June 2015 in Quimitéchnica.com and José de Mello v Commission; |
| --- | --- |

1.

Sets aside the judgment of the General Court of the European Union of 26 June 2015 in Quimitéchnica.com and José de Mello v Commission;

| 2. | Refers the matter back before the General Court of the European Union; |
| --- | --- |

2.

Refers the matter back before the General Court of the European Union;

| 3. | Reserves the costs. |
| --- | --- |

3.

Reserves the costs.

---

(1)  OJ C 388, 3.11.2014.

1

---
No. 10-31.

#### Ana Boatwright, Warden, Petitioner v. Elliot D. Ray.

562 U.S. 1044, 131 S. Ct. 595,

178 L. Ed. 2d 434,

2010 U.S. LEXIS 8983.

November 15, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.

Same case below, 592 F.3d 793.
[Federal Register Volume 63, Number 16 (Monday, January 26, 1998)]
[Notices]
[Page 3727]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-1680]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. RP97-8-008]


Granite State Gas Transmission, Inc.; Notice of Refund Report

January 20, 1998.
    Take notice that on December 23, 1997, Granite State Gas 
Transmission, Inc., (Granite State) tendered for filing a report of 
refunds to its transportation service customers, pursuant to the 
Stipulation and Agreement approved by the Commission on October 20, 
1997.
    Granite State's report indicates that the refund period extends 
from April 1, 1997 when the motion rates became effective to November 
1, 1997, when the Phase I settlement rates became effective. The report 
also indicates that on December 11, 1997, Granite State made refunds of 
$561,643.55 including interest calculated to that date.
    Granite State notes that copies of its filing have been served on 
its firm and interruptible customers, and on the regulatory agencies of 
the states of Maine, Massachusetts and New Hampshire.
    Any person desiring to protest said filing should file a protest 
with the Federal Energy Regulatory Commission, 888 First Street, N.E., 
Washington, D.C. 20426, in accordance with Section 385.211 of the 
Commission's Rules of Practice and Procedure. All such protests should 
be filed on or before January 27, 1998. Protests will be considered by 
the Commission in determining the appropriate action to be taken, but 
will not serve to make protestants parties to the proceeding. Copies of 
this filing are on file with the Commission and are available for 
public inspection in the Public Reference Room.
David P. Boergers,
Acting Secretary.
[FR Doc. 98-1680 Filed 1-23-98; 8:45 am]
BILLING CODE 6717-01-M
CS234967F

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

Division of Tuberculosis Elimination

What You Need to Know About Your Medicine 

for Latent Tuberculosis (TB) Infection

RIFAMPIN

You have been given medicine to treat your latent TB infection. You do not have 

TB disease and cannot spread TB to others. This medicine will help you PREVENT

getting TB disease.

While on this Medicine:

• Tell your doctor or nurse if you have questions or concerns with the medicine.

• Go to your planned clinic visits.

• Discuss any alcohol use with your doctor. Alcohol use may cause side effects.

• Tell your doctor about all other medicines you are taking.

• Be sure to tell your other doctors that you are being treated for latent 

TB infection.

• Take all of your medicine as you were told by your TB doctor or nurse.

• Some people find that the medicine affects them less when taken with food.

Tips to Help You Take Your Medicine:

9 Take your medicine at the same time every day.

9 Set an alarm reminder for the time you should take your medicine.

9 Ask a family member or friend to remind you. 

9 Use a pillbox. 

9 Put a reminder note on your mirror or refrigerator.

9 Use a calendar to check off the day when you take your medicine.

Latent TB Infection Medicine Schedule:

(Providers: Indicate the appropriate number of pills)

Medicine Schedule Number of pills

per day

Length

of time

Rifampin Daily 4 months

Your doctor may have you meet with a health care worker to take your medicine. 

This plan is called directly observed therapy (DOT).

IF YOU FORGET TO TAKE YOUR MEDICINE: If it is still the same day, take the 

dose as soon as you remember. Do not take 2 doses at the same time.

NOTES

Name of my doctor:

Name of my clinic:

Telephone number of my clinic:

Watch for these Possible 

Problems: 

STOP taking your medicine right 

away AND call your TB doctor 

or nurse if you have any of the 

problems below:

• Less appetite, or no appetite 

for food

• An upset stomach or stomach 

cramps

• Nausea or vomiting

• Cola-colored urine or light 

stools

• Easy bruising or bleeding

• Rash or itching

• Yellowing skin or eyes

• Severe weakness or tiredness

• Fever

• Head or body aches

• Dizziness

NOTE: It is normal if your urine, 

saliva, or tears become orangecolored. Soft contact lenses may 

become stained.
No. 10-1336.

#### Michael A. Carroll, Petitioner v. Michael J. Astrue, Commissioner of Social Security.

565 U.S. 817, 132 S. Ct. 97,

181 L. Ed. 2d 26,

2011 U.S. LEXIS 6741,

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

Same case below, 402 Fed. Appx. 709.
Exhibit 32.1
 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  (1)
    
    The Companys Annual Report on Form 10-K for the year ended February 28, 2011, as filed
with the Securities Exchange Commission on the date hereof (the Report) fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended; and(2)
    
    Information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company as of the dates and for the
periods expressed in the Report.
 /S/ KEITH S. WALTERSKeith S. WaltersChairman of the Board and Chief Executive Officer 
May 10, 2011 The foregoing Certification is being furnished solely pursuant to 18 U.S.C. Section 1350; it is not
being filed for purposes of Section 18 of the Securities Exchange Act, and is not to be
incorporated by reference into any filing of the Company, whether made before or after the date
hereof, regardless of any general incorporation languages in such filing.
National Depression 

and Mental Health Awareness 

and Screening Month

Depression is real, common and treatable. Recovery is possible.

SYMPTOMS

Isolation 

Lack of energy

Trouble sleeping 

Substance misuse

Anger or sadness

WHAT YOU CAN DO

See your doctor or 

contact your program

Get screened

Learn about self-help

B-P2252E (8/22) ©2022 Magellan Health, Inc. 

Help is available. Contact your Employee Assistance

Program at MagellanAscend.com or 1-866-580-9046

(TTY 711).
Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


E-learning Institute Fellowship


Section Navigation
			
			CDC Home








Apply to ELI						Print
																Related Pages
										ELI is paused for 2024. Please check back in Fall 2024 for updates to apply to ELI 2025.Follow these four steps to apply to ELI. You must be willing to commit to this 6-month, online fellowship.1
				Check Eligibility
			2
				Review Frequently Asked Questions
			3
				Prepare Application Info
			4
				Complete Online Application
							
					
							Last Reviewed:  August 25, 2023						Source: 	Deputy Director for Public Health Science and Surveillance, Center for Surveillance, Epidemiology, and Laboratory Services, Division of Scientific Education and Professional Development
					Facebook
        Twitter
        LinkedIn
        Syndicate homeE-learning Institute Fellowship
Apply to ELIplus icon
Check Eligibility
Review Frequently Asked Questions
Prepare Application Info
Complete Online Application
About ELIplus icon
Meet the Fellowsplus icon
Alumni
Meet the Mentors
Become a Mentor
Graduate Testimonials
Product Examples Develop Training


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2865 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 2865

  To establish a grant program to incentivize States to reduce prison 
                  populations, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 21, 2019

  Mr. Cardenas (for himself, Ms. Schakowsky, Ms. Norton, Mrs. Watson 
Coleman, Mr. Payne, Mr. Cohen, Mrs. Demings, Ms. Moore, Mr. Johnson of 
   Georgia, and Mr. Trone) introduced the following bill; which was 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
  To establish a grant program to incentivize States to reduce prison 
                  populations, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Reverse Mass Incarceration Act of 
2019''.

SEC. 2. GRANT PROGRAM.

    (a) In General.--Title I of the Omnibus Crime Control and Safe 
Street Act of 1968 (42 U.S.C. 3711 et seq.) is amended by adding at the 
end the following:

       ``PART OO--STATE PRISON POPULATION REDUCTION GRANT PROGRAM

``SEC. 3051. GRANT PROGRAM.

    ``(a) In General.--The Attorney General may make grants to States 
to assist States in reducing crime rates and incarcerations.
    ``(b) Eligibility.--A State shall be eligible to receive a grant 
under this section if the State demonstrates that, during the 3-year 
period preceding the application for a grant under this section--
            ``(1) the total number of individuals incarcerated in 
        correctional or detention facilities in the State was reduced 
        by not less than 7 percent; and
            ``(2) the rate of crime within the State did not increase 
        by more than 3 percent.
    ``(c) Application.--An eligible State seeking a grant under this 
section shall submit to the Attorney General an application in such 
form and manner and at such time as the Attorney General requires, 
which shall include a clear methodology based on population size and 
other factors.
    ``(d) Use of Grant Funds.--A grant awarded under this section shall 
be used by a State to implement evidence-based programs designed to 
reduce crime rates and incarcerations.''.
    (b) Authorization of Appropriations.--Section 1001(a) of title I of 
the Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 
3793(a)) is amended by adding at the end the following:
    ``(28) There are authorized to be appropriated to carry out part OO 
$2,000,000,000 for each of fiscal years 2020 through 2029.''.
                                 <all>
```
No. 10-7112.

#### In re Lester Jon Ruston, Petitioner.

562 U.S. 1060, 131 S. Ct. 671,

2010 U.S. LEXIS 9369.

178 L. Ed. 2d 517,

November 29, 2010.

Motion of petitioner for leave to proceed in forma pau-peris denied, and petition for writ of mandamus dismissed. See Rule 39.8.
No. 10-7380.

#### Paul Narvios, Petitioner v. Anthony A. Lamarque, Warden.

562 U.S. 1115, 131 S. Ct. 837,

2010 U.S. LEXIS 9682.

178 L. Ed. 2d 568,

December 13, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 391 Fed. Appx. 662.
Electronically FiledIntermediate Court of AppealsCAAP-11-000039427-SEP-201108:55 AM
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 01-7462

GENE ALLEN HERROLD, Petitioner - Appellant, versus J. E. GUNJA, Warden, Respondent - Appellee. Appeal from the United States District Court for the District of Maryland, at Baltimore. William M. Nickerson, District Judge. (CA-01-1560-WMN) Submitted: November 26, 2001 Decided: December 12, 2001 Before NIEMEYER and MICHAEL, Circuit Judges, and HAMILTON, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Gene Allen Herrold, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Gene Allen Herrold appeals the district court’s order and order on reconsideration denying relief on his 28 U.S.C. § 2241 (1994) petition. We have reviewed the record and the districtcourt’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See Herrold v. Gunja , No. CA-01-1560-WMN (D. Md. filed June 1, 2001, entered June 4, 2001; filed July 25, 2001, entered July 25, 2001). We dispense withoral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
EXHIBIT 32.1





CERTIFICATION OF CHIEF EXECUTIVE OFFICER


PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




I, William C. Bopp, certify to my knowledge pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Viking Systems, Inc. on Form 10-Q for the quarterly period ended June 30, 2009, fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Viking Systems, Inc.







Date: August 7, 2009
/s/ William C. BoppWilliam C. BoppChief Executive Officer
#### Ana F. Lee-Csoke, Appellant, v Mid-Hudson Civic Center, Inc., Doing Business as Ice Time Sports Complex, Respondent.

[53 NYS3d 553]

In an action to recover damages for personal injuries, the plaintiff appeals from an order of the Supreme Court, Orange County (Bartlett, J.), dated December 14, 2015, which granted the defendant’s motion for summary judgment dismissing the complaint.

Ordered that the order is affirmed, with costs.

The plaintiff allegedly was injured while ice skating at the defendant’s premises on rented skates when her ankle twisted causing her to slip and fall on the ice. Before the accident, the plaintiff had requested size 71⁄2 skates at the rental counter but was informed that her size was not available and she was given larger size skates to try. Prior to entering the ice rink, the plaintiff noticed that the skates were large, heavy, and lacked support around her ankle. Nevertheless, she skated for 10 minutes before the skates became too uncomfortable and she slipped while exiting the rink. Thereafter, the plaintiff commenced this action to recover damages for personal injuries. The defendants moved for summary judgment dismissing the complaint. The Supreme Court granted the motion.

The doctrine of primary assumption of risk precludes a voluntary participant in certain sporting events or recreational activities from recovering for those injuries that may foresee-ably result from the realization of a risk inherent in the activity itself *(see Morgan v State of New York,*90 NY2d 471, 484 [1997]; *Miskanic v Roller Jam USA, Inc.,*71 AD3d 1102, 1103 [2010]; *Cotty v Town of Southampton,*64 AD3d 251, 253-254 [2009]). The doctrine of primary assumption of the risk, however, will not serve as a bar to liability if the risk is unassumed, concealed, or unreasonably increased *(see Morgan v State of New York,*90 NY2d at 484; *Ribaudo v La Salle Inst.,*45 AD3d 556, 557 [2007]). Here, the defendant established, prima facie, that the action was barred by the doctrine of primary assumption of risk. In opposition, the plaintiff failed to *711raise a triable issue of fact as to whether the risk was unreasonably increased so that the doctrine of primary assumption of risk would not apply *(see Morgan v State of New York,*90 NY2d at 484; *see also Geffen v City of New York,*271 AD2d 487, 487 [2000]; *Papakanakis v City of New York,*229 AD2d 353 [1996]).

Accordingly, the Supreme Court properly granted the defendant’s motion for summary judgment dismissing the complaint.

Dillon, J.P., Cohen, Duffy and Connolly, JJ., concur.
Exhibit 32.2

                               ENVIROKARE TECH INC
                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO SECTION 906 OF
                         THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly  Report of Envirokare  Tech, Inc. (the Company)
on Form 10-QSB for the period ended March 31, 2004 as filed with the  Securities
and Exchange  Commission on the date hereof (the Report),  I, George  Kazantzis,
Chief  Operating  Officer and acting  Chief  Financial  Officer of the  Company,
certify,  pursuant to 18 U.S.C.  ss.1350,  as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Odyssey  Pictures  Corporation  and will be  retained  by  Odyssey
Pictures  Corporation and furnished to the Securities and Exchange Commission or
its staff upon request.


May 21, 2004

/s/  George Kazantzis
---------------------------
George Kazantzis
Chief Operating Officer and
acting Chief Financial Officer
No. 10-1382.

#### John E. Reardon, Petitioner v. Mr. Leason, et al.

565 U.S. 818, 132 S. Ct. 102,

181 L. Ed. 2d 29,

2011 U.S. LEXIS 6946.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

*30Same case below, 408 Fed. Appx. 551.